Truist Financial’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Truist Financial’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-72,790	Closed	-$226K	–	2926
2021 Q4	$226K	Hold	72,790	–	–	﹤0.01%	2528
2021 Q3	$263K	Buy	+72,790	New	+$275K	﹤0.01%	2423

Other funds holding BDSI

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

FCMT

Founders Capital Management (Texas) Houston, Texas $231M AUM 61.68% 1-Year Est. Return

Truist Financial's BDSI Position: Q1 2022 in Review

Truist Financial sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 72,790 shares — an estimated $226K sold.

Truist Financial first reported a position in BDSI in Q3 2021 and held it in 2 quarters. The position peaked at $263K in Q3 2021. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

Truist Financial reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
Truist Financial sold 72,790 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $226K.
Truist Financial first reported a position in BioDelivery Sciences International, Inc. in Q3 2021 and held it in 2 quarters.
Truist Financial's BioDelivery Sciences International, Inc. position peaked at $263K in Q3 2021.
2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Truist Financial's 13F filing for Q1 2022, filed 22 Apr 2022.